[no subject]

["Nyfort-Hansen, Karin " <Karin.Nyfort-Hansen@rgh.sa.gov.au>]

<7B397AD17A82D411A1E5000629D53F860427A0BA@rex.rgh.sa.gov.au>
Subject: [india-drug] Response to Drug Trials in India
Sender: owner-india-drug@usa.healthnet.org
Precedence: bulk
Reply-To: india-drug@usa.healthnet.org

Dear Cerissa,

I would be very interested to read your story once it is completed. 
Will you be making it available to India Drug subscribers?

Best wishes

Karin Nyfort-Hansen

Clinical Pharmacist
Pharmacy Department
Repatriation General Hospital
Daw Park
SA 5041
Tel: (08) 8275 1085
Fax: 8374 0225
Email: karin.nyfort-hansen@rgh.sa.gov.au





________________________________________________________________________
Yahoo! India Insurance Special: Be informed on the best policies, services, tools and more. 
Go to: http://in.insurance.yahoo.com/licspecial/index.html

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org